Gene therapy for glioblestome multiforme: In vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir

被引：20

作者：

Stockhammer, G

Brotchi, J

Leblanc, R

Bernstein, M

Schackert, G

Weber, F

Ostertag, C

Mulder, NH

Mellstedt, H

Seiler, R

Yonekawa, Y

Twerdy, K

Kostron, H

DeWitte, O

Lambermont, M

Velu, T

Laneuville, P

Villemure, JG

Rutka, JT

Warnke, P

Laseur, M

Mooij, JJA

Boethius, J

Mariani, L

Meyer, M

Brandli, C

Frei, K

Konu, D

GianellaBorradori, A

机构：

[1] SANDOZ PHARMA LTD, CH-4002 BASEL, SWITZERLAND

[2] UNIV INNSBRUCK, A-6020 INNSBRUCK, AUSTRIA

[3] FREE UNIV BRUSSELS, HOP ERASME, B-1070 BRUSSELS, BELGIUM

[4] MCGILL UNIV, MONTREAL NEUROL INST, MONTREAL, PQ, CANADA

[5] ROYAL VICTORIA HOSP, MONTREAL, PQ H3A 1A1, CANADA

[6] TORONTO HOSP, TORONTO, ON M5T 2S8, CANADA

[7] HOSP SICK CHILDREN, TORONTO, ON M5G 1X8, CANADA

[8] UNIV KLINIKUM KARL GUSTAV CARUS, DRESDEN, GERMANY

[9] UNIV KLINIKUM, DUSSELDORF, GERMANY

[10] NEUROZENTRUM FREIBURG, FREIBURG, GERMANY

[11] UNIV GRONINGEN HOSP, GRONINGEN, NETHERLANDS

[12] KAROLINSKA HOSP, S-10401 STOCKHOLM, SWEDEN

[13] UNIV BERN, INSELSPITAL, CH-3010 BERN, SWITZERLAND

[14] UNIV SPITAL ZURICH, ZURICH, SWITZERLAND

来源：

JOURNAL OF MOLECULAR MEDICINE-JMM | 1997年 / 75卷 / 04期

关键词：

D O I：

10.1007/s001090050116

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

[No abstract available]

引用

页码：300 / 304

页数：5

共 50 条

[21] In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration
Tong, XW
Block, A
Chen, SH
Contant, CF
Agoulnik, I
Blankenburg, K
Kaufman, RH
Woo, SLC
Kieback, DG
GYNECOLOGIC ONCOLOGY, 1996, 61 (02) : 175 - 179
[22] Limited efficacy of gene transfer in herpes simplex virus-thymidine kinase/ganciclovir gene therapy for brain tumors
Hadaczek, P
Mirek, H
Berger, MS
Bankiewicz, K
JOURNAL OF NEUROSURGERY, 2005, 102 (02) : 328 - 335
[23] Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase ganciclovir-mediated gene therapy
Park, JY
Elshami, AA
Amin, K
Rizk, N
Kaiser, LR
Albelda, SM
GENE THERAPY, 1997, 4 (09) : 909 - 917
[24] Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy
JY Park
AA Elshami
K Amin
N Rizk
LR Kaiser
SM Albelda
Gene Therapy, 1997, 4 : 909 - 917
[25] Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir
Haberkorn, U
Altmann, A
Morr, I
Germann, C
Oberdorfer, F
vanKaick, G
JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (07) : 1048 - 1054
[26] Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy
Ketola, A
Määttä, AM
Pasanen, T
Tulimäki, K
Wahlfors, J
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2004, 13 (05) : 705 - 710
[27] Herpes simplex virus thymidine kinase gene/ganciclovir gene therapy for primary malignant glioma: Results of a phase III study
Rainov, NG
CANCER GENE THERAPY, 2000, 7 (08) : 1208 - 1208
[28] Anti-tumor natural killer cells are induced by herpes simplex virus thymidine kinase gene transduction and ganciclovir therapy in a mouse model of prostate cancer.
Atkinson, G
Sanford, MA
Zaslau, S
Chen, SH
Hall, SJ
JOURNAL OF UROLOGY, 1998, 159 (05): : 8 - 8
[29] A phase I trial of in vivo gene therapy with the herpes simplex thymidine kinase ganciclovir system for the treatment of refractory or recurrent ovarian cancer
Link, CJ
Moorman, D
Seregina, T
Levy, JP
Schabold, KJ
HUMAN GENE THERAPY, 1996, 7 (09) : 1161 - 1179
[30] Immunotherapy of murine prostate cancer using whole tumor cells killed ex vivo by herpes simplex viral thymidine kinase/ganciclovir suicide gene therapy
Pandha, H
Eaton, J
Greenhalgh, R
Soars, D
Dalgleish, A
CANCER GENE THERAPY, 2005, 12 (06) : 572 - 578

← 1 2 3 4 5 →